ISPE Bio Event Examines Approaches for Optimizing Operational Agility and Time-to-Launch Readiness

The International Society for Pharmaceutical Engineering (ISPE) revealed its Biopharmaceutical Manufacturing Conference, happening December 4–6, 2017 in San Francisco, CA. The event will focus on optimizing operational and process development approaches to improve speed-of-launch readiness. 

“As companies prepare for the increased demand for facility improvements, design, and manufacturing resources, operational agility and faster time-to-launch readiness are two key factors that will have an impact on their success,” stated ISPE CEO and President John Bournas.

The conference will include keynote speakers from organizations such as BioMarin, Kite Pharma, FDA, Avara, and Gilead Sciences. Additionally, three educational courses, complete with informative sessions, will provide attendees insight from industry, supervisory, and academic specialists.